MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

MBQ-167

CAS No. : 2097938-73-1

MCE 国际站：MBQ-167

产品活性：MBQ-167 是 Ras 相关的 C3 型肉毒素底物 (Rac) 和细胞分裂周期蛋白 (Cdc42) 的双抑制剂，其对 Rac 1/2/3 的 IC₅₀ 值为 103 nM， 对 Cdc42 的 IC₅₀ 值为 78 nM。

研究领域：GPCR/G Protein | Cell Cycle/DNA Damage

作用靶点：Ras | CDK

In Vitro: MBQ-167 (≥100 nM) induces a loss of polarity in metastatic breast cancer cells. Treatment with 500 nM MBQ-167 for 24 h results in ~95% cell rounding and detachment from the substratum in metastatic MDA-MB-231 cells. Moreover, MBQ-167 induces this phenotype in multiple mesenchymal cancer cell types including GFP-HER2-BM, MDA-MB-468, and Hs578t human breast cancer cells, as well as Mia-PaCa-2 pancreatic cancer cells, SKOV3 ovarian cancer cells, AGS and NCI-N87 gastric cancer cells, and SH-SY5Y neuroblastoma cells. Following treatment with 250 nM MBQ-167 for 24 h, the attached population of MDA-MB-231 cells demonstrate a ~25% decrease in Rac activation while the detached cells are more responsive with a ~75% decrease. At earlier times (6h), treatment with 250 or 500 nM MBQ-167, induce a inhibition in Rac activity in the attached cell population, while the detached population demonstrate a ~40-50% inhibition.

In Vivo: MBQ-167-treated mice demonstrate a statistically significant reduction in tumor growth. At sacrifice, 1.0 mg/kg BW of MBQ-167 results in a ~80% reduction in tumor growth, and the 10 mg/kg BW MBQ-167 treatment results in ~95% reduction in tumor growth. Since EHop-016 only exerts ~40% reduction of tumor growth at 10 mg/kg BW, MBQ-167 is 10X more effective than EHop-016. MBQ-167 treated mice demonstrate similar doubling times for both treatments (10 and 11 days).

相关产品：Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | GPCR/G Protein Compound Library | Kinase Inhibitor Library | Anti-Cancer Compound Library | Anti-Aging Compound Library | Ferroptosis Compound Library | Glutamine Metabolism Compound Library | Anti-Breast Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Angiogenesis Related Compound Library | Sotorasib | Palbociclib | MRTX849 | Abemaciclib | Dinaciclib | BI-2852 | Ribociclib | Ro-3306 | THZ1 | THZ531 | BI-3406 | Seliciclib | AZD4573 | Flavopiridol | ARS-1620 | NSC 23766 trihydrochloride | PF-06873600 | SR-4835 | BAY-293 | Ketoconazole | Simurosertib | NVP-2 | CYC065 | MRTX-1257 | ML141 | Rhosin hydrochloride | Zotiraciclib

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种TOP期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪前沿的制药及生命科学研究进展，为您提供全球前沿的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。